PROVIDER PROFILE · NPI 1952697872

Melissa SpringmeyerM.D.

Family PracticeJacksonville, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

524

Unique beneficiaries

—

Total services

2,072

Distinct HCPCS

Medicare payment

$111K

Peer benchmark

Total Medicare services vs. 6,385 Family Practice providers in TX — top quintile (cohort median 567).

PRESCRIBING · PART D · 2024

Total Rx claims

399

Beneficiaries

—

Total drug cost

$19K

Distinct drugs

Brand share

39.3%

Top prescribed drugs

Acetaminophen With Codeine81 claims

Doxycycline Monohydrate75 claims

Ciprofloxacin Hcl42 claims

Gentamicin Sulfate36 claims

Ceftriaxone Sodium35 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$24

Payment records

By payment type

Food and Beverage$24

REFERRAL NETWORK

Where Melissa Springmeyer's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Thomas Howe General Surgery · Lubbock, TX	52	707
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	49	406
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	14	57
LUBBOCK RADIOLOGY LP	13	60
SPECTRA LABORATORIES INC	12	102
Brian Bruening Diagnostic Radiology · Lubbock, TX	11	40
Piyush Mittal Internal Medicine · Lubbock, TX	11	225

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history